Children with spina bifida, a malformation of the spinal cord that can lead to mobility impairments and hydrocephalus — a buildup of fluid in the brain — face significant risk of cognitive difficulties throughout their lives. A new multi-center study led by researchers at Washington University School of Medicine in St. Louis and Michigan Medicine […]
“Napping is not inherently a bad idea,” as long as you’re able to do it right, says Yo-El S. Ju, MD, a sleep physician scientist and Barbara Burton and Reuben Morriss III professor of neurology at the Washington University School of Medicine. If you can’t beat the post-lunch slump, a quick nap might help you […]
The GLUT1 Deficiency Foundation has designated WashU Medicine / St. Louis Children’s Hospital as a GLUT1 Collaborative Care Center of Excellence. This prestigious designation places WashU Medicine Neurology among only 25 such centers worldwide. GLUT1 deficiency is a rare genetic disorder affecting the movement of glucose across the blood-brain barrier, leading to various neurological challenges. […]
Startup companies built on Washington University in St. Louis discoveries attracted a record $1.7 billion in private-sector investment over the past year, accelerating the commercialization of WashU innovations into life-changing diagnostics, therapeutics and medical devices. Among those innovations are a blood test to diagnose Alzheimer’s disease; immunotherapies to treat aggressive blood cancers; and an AI-based […]
New research suggests that prescription stimulants for ADHD don’t actually improve attention directly. They work on different pathways in the brain that support attention.
Prescription stimulants, such as Ritalin and Adderall, are widely used to treat attention deficit hyperactivity disorder (ADHD), including in children. In the U.S., about 3.5 million kids ages 3 to 17 take an ADHD medication, a number that has increased as more children have been diagnosed with the neurodevelopmental disorder.
A new drug may slow progression of — and even reverse — symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very specific mutation — SOD1 — which applies to only 2% of the ALS population. Among this group, the drug has the potential […]
Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline of neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, researchers from Washington University School of Medicine in St. Louis and collaborators report that long-term use of tofersen, a new drug approved by the Food and Drug […]
Congratulations to the members of the Department of Neurology who received accolades through the Supporting a Fair Environment (SAFE) program! SAFE aims to improve the learning environment by promoting positive behaviors and managing concerns about learner mistreatment and unprofessional behaviors. SAFE accolades include treating others with dignity and respect, creating an environment that values diversity, […]
WashU Medicine is proud to celebrate two distinguished faculty members — Jeffrey R. Millman, PhD, and Jin-Moo Lee, MD, PhD — as recipients of the Dr. Ralph & Marian Falk Medical Research Trust Catalyst Award. This competitive award supports bold, early-stage research that has the potential to transform patient care. The Trust is managed by Health […]